As we grow our firm and find new platform investment opportunities in fast-growing lower middle-market healthcare companies, all of us at NaviMed are very excited to be expanding our team with such high quality and experienced professionals.
WASHINGTON (PRWEB)
July 30, 2020
NaviMed Capital, a leading healthcare-focused private equity firm based in Washington, DC, today announced the expansion of its team with the addition of two experienced investment professionals as well as an accomplished CFO/CCO.
-
Josh Boylan – Vice President
Mr. Boylan joins NaviMed Capital with more than five years of healthcare private equity investing experience at several well-regarded firms. At NaviMed he will focus on expanding the firm’s investment activity in hospital products, as well as contract development, manufacturing and distribution companies serving the healthcare industry.
At his prior private equity firms, Mr. Boylan was integrally involved in investments in contract manufacturing, pharmaceutical manufacturing and distribution, and hospital products.
Earlier in his career, Mr. Boylan served in the United States Senate as an Economic Policy Fellow focused on Medicare and Medicaid reform. In addition, Mr. Boylan has global healthcare investment banking experience.
Mr. Boylan earned a BS in Economic History from the London School of Economics and Political Science, where he graduated with first class honours.
- Henry Oelsner – Associate
Mr. Oelsner has several years of private equity and transaction advisory experience. Prior to joining NaviMed Capital, Mr. Oelsner spent two years at a growth-oriented private equity firm focused on investing in leading healthcare, software, and tech-enabled services companies. As part of that role, Mr. Oelsner focused on the firm’s investments in healthcare IT and played an integral role in the acquisitions of several platform investments.
Mr. Oelsner started his career in investment banking where he completed sell-side advisory transactions for growth-focused companies across a range of industry sectors.
Mr. Oelsner graduated with distinction from the University of Virginia’s McIntire School of Commerce, receiving a BS in Commerce with dual concentrations in Finance and Accounting.
Mr. Macklin has more than 20 year of experience in the private equity industry, principally as a Chief Financial Officer and Chief Compliance Officer. At NaviMed, Mr. Macklin oversees critical operational areas including finance and accounting, investor reporting, and regulatory compliance.
Mr. Macklin’s industry experience includes senior financial roles at several leading private equity firms with aggregate assets under management in excess of $2 billion. Mr. Macklin started his career in public accounting and also has held positions at asset management and investment firms.
Mr. Macklin is a Certified Public Accountant (inactive) and a Chartered Financial Analyst (active). He holds a BS in Mathematics from the College of William and Mary and an MBA from the Wharton School of the University of Pennsylvania.
These three additions join NaviMed’s senior investment team that has a track record of value creation spanning, in the aggregate, dozens of investments and more than $11 billion of enterprise value created over the course of their collective careers, with decades of combined healthcare investing and operating experience.
“As we grow our firm and find new platform investment opportunities in fast-growing lower middle-market healthcare companies, all of us at NaviMed are very excited to be expanding our team with such high quality and experienced professionals,” said Bijan Salehizadeh, Managing Director of NaviMed Capital.
“We believe that the global coronavirus pandemic will increase the already robust demand dynamics in the hospital products industry. We are very pleased to add a professional with Josh’s sector experience as we expand our efforts to target this large opportunity,” said Ryan Schwarz, Managing Director of NaviMed Capital.
“As NaviMed grows, so does the intensity of limited partner relations, financial management and compliance matters. We feel fortunate to be joined by Rodd, who is one of the most experienced private equity CFO/CCOs in the Washington DC region,” said Brian Canann, Managing Director of NaviMed Capital.
About NaviMed Capital
NaviMed Capital is a Washington, DC-based private capital firm focused exclusively on the healthcare industry. NaviMed makes investments in fast growing lower middle-market healthcare businesses. The firm focuses on healthcare services, healthcare IT, hospital products and pharmaceutical services businesses which NaviMed believes are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. NaviMed targets profitable private companies with up to $10 million of EBITDA and double digit revenue growth. NaviMed seeks investments which it believes can benefit from its deep industry expertise, broad relationship network and the track record of success of its senior investment professionals as healthcare investors and operators. NaviMed’s senior investment team has a track record of value creation spanning, in the aggregate, dozens of investments and more than $11 billion of enterprise value created over the course of their combined careers.
For more information, please visit http://www.navimed.com.
Share article on social media or email: